Antitumour dendritic cell vaccination in a priming and boosting approach
A Harari, M Graciotti, M Bassani-Sternberg… - Nature Reviews Drug …, 2020 - nature.com
Mobilizing antitumour immunity through vaccination potentially constitutes a powerful
anticancer strategy but has not yet provided robust clinical benefits in large patient …
anticancer strategy but has not yet provided robust clinical benefits in large patient …
Antitumour dendritic cell vaccination in a priming and boosting approach
A Harari, M Graciotti… - Nature reviews …, 2020 - pubmed.ncbi.nlm.nih.gov
Mobilizing antitumour immunity through vaccination potentially constitutes a powerful
anticancer strategy but has not yet provided robust clinical benefits in large patient …
anticancer strategy but has not yet provided robust clinical benefits in large patient …
Antitumour dendritic cell vaccination in a priming and boosting approach.
A Harari, M Graciotti, M Bassani-Sternberg… - Nature reviews. Drug …, 2020 - sonar.ch
English Mobilizing antitumour immunity through vaccination potentially constitutes a
powerful anticancer strategy but has not yet provided robust clinical benefits in large patient …
powerful anticancer strategy but has not yet provided robust clinical benefits in large patient …
Antitumour dendritic cell vaccination in a priming and boosting approach.
A Harari, M Graciotti, M Bassani-Sternberg… - Nature Reviews Drug …, 2020 - go.gale.com
Mobilizing antitumour immunity through vaccination potentially constitutes a powerful
anticancer strategy but has not yet provided robust clinical benefits in large patient …
anticancer strategy but has not yet provided robust clinical benefits in large patient …
Antitumour dendritic cell vaccination in a priming and boosting approach.
A Harari, M Graciotti, M Bassani-Sternberg… - Nature reviews. Drug …, 2020 - folia.unifr.ch
English Mobilizing antitumour immunity through vaccination potentially constitutes a
powerful anticancer strategy but has not yet provided robust clinical benefits in large patient …
powerful anticancer strategy but has not yet provided robust clinical benefits in large patient …
[引用][C] Antitumour dendritic cell vaccination in a priming and boosting approach
A Harari, M Graciotti, M Bassani-Sternberg… - Nature Reviews Drug …, 2020 - cir.nii.ac.jp
Antitumour dendritic cell vaccination in a priming and boosting approach | CiNii Research CiNii
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
Antitumour dendritic cell vaccination in a priming and boosting approach.
A Harari, M Graciotti, M Bassani-Sternberg… - Nature reviews. Drug …, 2020 - europepmc.org
Mobilizing antitumour immunity through vaccination potentially constitutes a powerful
anticancer strategy but has not yet provided robust clinical benefits in large patient …
anticancer strategy but has not yet provided robust clinical benefits in large patient …